Inhibitory effect of anti-malarial agents on the expression of proinflammatory chemokines via Toll-like receptor 3 signaling in human glomerular endothelial cells

Objective Although anti-malarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ) are currently used for the treatment of systemic lupus erythematosus, their efficacy for lupus nephritis (LN) remains unclear. Given that upregulation of glomerular Toll-like receptor 3 (TLR3) signaling plays a pi...

Full description

Bibliographic Details
Main Authors: Riko Sato, Tadaatsu Imaizumi, Tomomi Aizawa, Shojiro Watanabe, Koji Tsugawa, Shogo Kawaguchi, Kazuhiko Seya, Tomoh Matsumiya, Hiroshi Tanaka
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Renal Failure
Subjects:
Online Access:http://dx.doi.org/10.1080/0886022X.2021.1908901
_version_ 1818332503291723776
author Riko Sato
Tadaatsu Imaizumi
Tomomi Aizawa
Shojiro Watanabe
Koji Tsugawa
Shogo Kawaguchi
Kazuhiko Seya
Tomoh Matsumiya
Hiroshi Tanaka
author_facet Riko Sato
Tadaatsu Imaizumi
Tomomi Aizawa
Shojiro Watanabe
Koji Tsugawa
Shogo Kawaguchi
Kazuhiko Seya
Tomoh Matsumiya
Hiroshi Tanaka
author_sort Riko Sato
collection DOAJ
description Objective Although anti-malarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ) are currently used for the treatment of systemic lupus erythematosus, their efficacy for lupus nephritis (LN) remains unclear. Given that upregulation of glomerular Toll-like receptor 3 (TLR3) signaling plays a pivotal role in the pathogenesis of LN, we examined whether CQ and HCQ affect the expression of the TLR3 signaling-induced representative proinflammatory chemokines, monocyte chemoattractant protein-1 (MCP-1), and C–C motif chemokine ligand 5 (CCL5) in cultured human glomerular endothelial cells (GECs). Methods We examined the effect of polyinosinic-polycytidylic acid (poly IC), an agonist of TLR3, on MCP-1, CCL5 and interferon (IFN)-β expression in GECs. We then analyzed whether pretreatment with CQ, HCQ, or dexamethasone (DEX) inhibits poly IC-induced expression of these chemokines using real-time quantitative reverse transcriptase PCR and ELISA. Phosphorylation of signal transducers and activator of transcription protein 1 (STAT1) was examined using western blotting. Results Poly IC increased MCP-1 and CCL5 expression in a time- and concentration-dependent manner in GECs. Pretreating cells with CQ, but not DEX, attenuated poly IC-induced MCP-1 and CCL5 expression; however, HCQ pretreatment attenuated poly IC-induced CCL5, but not MCP-1. HCQ did not affect the expression of IFN-β and phosphorylation of STAT-1. Conclusion Considering that TLR3 signaling is implicated, at least in part, in LN pathogenesis, our results suggest that anti-malarial agents exert a protective effect against the development of inflammation in GECs, as postulated in LN. Interestingly, CQ is a rather powerful inhibitor compared with HCQ on TLR3 signaling-induced chemokine expression in GECs. In turn, these findings may further support the theory that the use of HCQ is safer than CQ in a clinical setting. However, further detailed studies are needed to confirm our preliminary findings.
first_indexed 2024-12-13T13:36:47Z
format Article
id doaj.art-dd186af8fa074bd6aaf1b9d29f6fabd3
institution Directory Open Access Journal
issn 0886-022X
1525-6049
language English
last_indexed 2024-12-13T13:36:47Z
publishDate 2021-01-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj.art-dd186af8fa074bd6aaf1b9d29f6fabd32022-12-21T23:43:46ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492021-01-0143164365010.1080/0886022X.2021.19089011908901Inhibitory effect of anti-malarial agents on the expression of proinflammatory chemokines via Toll-like receptor 3 signaling in human glomerular endothelial cellsRiko Sato0Tadaatsu Imaizumi1Tomomi Aizawa2Shojiro Watanabe3Koji Tsugawa4Shogo Kawaguchi5Kazuhiko Seya6Tomoh Matsumiya7Hiroshi Tanaka8Department of Pediatrics, Hirosaki University HospitalDepartment of Vascular Biology, Hirosaki University Graduate School of MedicineDepartment of Pediatrics, Hirosaki University HospitalDepartment of Pediatrics, Hirosaki University HospitalDepartment of Pediatrics, Hirosaki University HospitalDepartment of Vascular Biology, Hirosaki University Graduate School of MedicineDepartment of Vascular Biology, Hirosaki University Graduate School of MedicineDepartment of Vascular Biology, Hirosaki University Graduate School of MedicineDepartment of Pediatrics, Hirosaki University HospitalObjective Although anti-malarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ) are currently used for the treatment of systemic lupus erythematosus, their efficacy for lupus nephritis (LN) remains unclear. Given that upregulation of glomerular Toll-like receptor 3 (TLR3) signaling plays a pivotal role in the pathogenesis of LN, we examined whether CQ and HCQ affect the expression of the TLR3 signaling-induced representative proinflammatory chemokines, monocyte chemoattractant protein-1 (MCP-1), and C–C motif chemokine ligand 5 (CCL5) in cultured human glomerular endothelial cells (GECs). Methods We examined the effect of polyinosinic-polycytidylic acid (poly IC), an agonist of TLR3, on MCP-1, CCL5 and interferon (IFN)-β expression in GECs. We then analyzed whether pretreatment with CQ, HCQ, or dexamethasone (DEX) inhibits poly IC-induced expression of these chemokines using real-time quantitative reverse transcriptase PCR and ELISA. Phosphorylation of signal transducers and activator of transcription protein 1 (STAT1) was examined using western blotting. Results Poly IC increased MCP-1 and CCL5 expression in a time- and concentration-dependent manner in GECs. Pretreating cells with CQ, but not DEX, attenuated poly IC-induced MCP-1 and CCL5 expression; however, HCQ pretreatment attenuated poly IC-induced CCL5, but not MCP-1. HCQ did not affect the expression of IFN-β and phosphorylation of STAT-1. Conclusion Considering that TLR3 signaling is implicated, at least in part, in LN pathogenesis, our results suggest that anti-malarial agents exert a protective effect against the development of inflammation in GECs, as postulated in LN. Interestingly, CQ is a rather powerful inhibitor compared with HCQ on TLR3 signaling-induced chemokine expression in GECs. In turn, these findings may further support the theory that the use of HCQ is safer than CQ in a clinical setting. However, further detailed studies are needed to confirm our preliminary findings.http://dx.doi.org/10.1080/0886022X.2021.1908901chloroquineglomerular endothelial cellshydroxychloroquinelupus nephritistoll-like receptor 3
spellingShingle Riko Sato
Tadaatsu Imaizumi
Tomomi Aizawa
Shojiro Watanabe
Koji Tsugawa
Shogo Kawaguchi
Kazuhiko Seya
Tomoh Matsumiya
Hiroshi Tanaka
Inhibitory effect of anti-malarial agents on the expression of proinflammatory chemokines via Toll-like receptor 3 signaling in human glomerular endothelial cells
Renal Failure
chloroquine
glomerular endothelial cells
hydroxychloroquine
lupus nephritis
toll-like receptor 3
title Inhibitory effect of anti-malarial agents on the expression of proinflammatory chemokines via Toll-like receptor 3 signaling in human glomerular endothelial cells
title_full Inhibitory effect of anti-malarial agents on the expression of proinflammatory chemokines via Toll-like receptor 3 signaling in human glomerular endothelial cells
title_fullStr Inhibitory effect of anti-malarial agents on the expression of proinflammatory chemokines via Toll-like receptor 3 signaling in human glomerular endothelial cells
title_full_unstemmed Inhibitory effect of anti-malarial agents on the expression of proinflammatory chemokines via Toll-like receptor 3 signaling in human glomerular endothelial cells
title_short Inhibitory effect of anti-malarial agents on the expression of proinflammatory chemokines via Toll-like receptor 3 signaling in human glomerular endothelial cells
title_sort inhibitory effect of anti malarial agents on the expression of proinflammatory chemokines via toll like receptor 3 signaling in human glomerular endothelial cells
topic chloroquine
glomerular endothelial cells
hydroxychloroquine
lupus nephritis
toll-like receptor 3
url http://dx.doi.org/10.1080/0886022X.2021.1908901
work_keys_str_mv AT rikosato inhibitoryeffectofantimalarialagentsontheexpressionofproinflammatorychemokinesviatolllikereceptor3signalinginhumanglomerularendothelialcells
AT tadaatsuimaizumi inhibitoryeffectofantimalarialagentsontheexpressionofproinflammatorychemokinesviatolllikereceptor3signalinginhumanglomerularendothelialcells
AT tomomiaizawa inhibitoryeffectofantimalarialagentsontheexpressionofproinflammatorychemokinesviatolllikereceptor3signalinginhumanglomerularendothelialcells
AT shojirowatanabe inhibitoryeffectofantimalarialagentsontheexpressionofproinflammatorychemokinesviatolllikereceptor3signalinginhumanglomerularendothelialcells
AT kojitsugawa inhibitoryeffectofantimalarialagentsontheexpressionofproinflammatorychemokinesviatolllikereceptor3signalinginhumanglomerularendothelialcells
AT shogokawaguchi inhibitoryeffectofantimalarialagentsontheexpressionofproinflammatorychemokinesviatolllikereceptor3signalinginhumanglomerularendothelialcells
AT kazuhikoseya inhibitoryeffectofantimalarialagentsontheexpressionofproinflammatorychemokinesviatolllikereceptor3signalinginhumanglomerularendothelialcells
AT tomohmatsumiya inhibitoryeffectofantimalarialagentsontheexpressionofproinflammatorychemokinesviatolllikereceptor3signalinginhumanglomerularendothelialcells
AT hiroshitanaka inhibitoryeffectofantimalarialagentsontheexpressionofproinflammatorychemokinesviatolllikereceptor3signalinginhumanglomerularendothelialcells